Literature DB >> 30953699

Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.

Xin-Meng Wang1, Qi-Yang Li2, Li-Li Ren3, Yi-Meng Liu4, Tian-Shi Wang5, Tian-Chi Mu2, Shuai Fu2, Chao Liu6, Jian-Ying Xiao7.   

Abstract

Microspherule protein 1(MCRS1) is known to be an oncogene in several tumors. However, recent studies have shown that MCRS1 inhibits lymphatic metastasis in gastric cancer (GC) patients by inhibiting telomerase activity. Protein kinase, membrane associated tyrosine/threonine 1(Pkmyt1), a member of the WEE1 family, has been found to interact with MCRS1 by yeast two-hybrid assay; however, how these two proteins interact in GC is still unclear. Hence, this study aimed to investigate the effect of MCRS1 interaction with Pkmyt1 on GC cell proliferation, migration, and invasion. Initially, we observed increased expression of MCRS1 in GC SGC-7901 cells and decreased expression in GC BGC-823 cells. Hence, we down-regulated MCRS1 expression in SGC-7901 cells and up-regulated it in BGC-823 cells. Our results showed that overexpression of MCRS1 inhibits the growth, invasion and migration of GC cells, while downregulation of MCRS1 promotes the growth, invasion and migration of GC cells. When MK1775, an inhibitor of WEE1 kinase, was added after downregulation of MCRS1, phenotypic recovery effects were observed. Overexpression of MCRS1 also inhibited the expression of Pkmyt1 and vice versa. This indicated that there might be a possible interaction between MCRS1 and Pkmyt1. Furthermore, immunoprecipitation assay revealed the interaction between MCRS1 and Pkmyt1 in virto, and immunofluorescence experiments showed that the two proteins were co-localized in the cytoplasm. In conclusion, our study confirmed the specific tumor suppressive activity of MCRS1 in GC proliferation, invasion and migration and suggested that it might inhibit the progression of GC through its interaction with Pkmyt1.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Invasion; MCRS1; Migration; Pkmyt1; Proliferation

Year:  2019        PMID: 30953699     DOI: 10.1016/j.cellsig.2019.04.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.

Authors:  Liang-Han Wang; Chih-Chun Chang; Chiao-Yin Cheng; Yao-Jen Liang; Dee Pei; Jen-Tang Sun; Yen-Lin Chen
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance.

Authors:  Qi-Yong Zhang; Xiao-Qin Chen; Xiong-Chang Liu; De-Ming Wu
Journal:  Onco Targets Ther       Date:  2020-08-04       Impact factor: 4.147

3.  Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells.

Authors:  Fang-Jie Hou; Li-Xiao Guo; Kai-Yan Zheng; Jun-Na Song; Qian Wang; Yu-Guang Zheng
Journal:  Onco Targets Ther       Date:  2019-08-19       Impact factor: 4.147

4.  Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma.

Authors:  Qingyi Zhang; Xuan Zhao; Chaoqi Zhang; Wei Wang; Feng Li; Donglei Liu; Kai Wu; Dengyan Zhu; Shasha Liu; Chunyi Shen; Xin Yuan; Kai Zhang; Yang Yang; Yi Zhang; Song Zhao
Journal:  Cancer Manag Res       Date:  2019-08-19       Impact factor: 3.989

5.  c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1.

Authors:  Peng Luo; Jiarui Fang; Houqing Chen; Feng He; Siying Xiao; He Liu; Shizhuang Zhu; Jianzhou Luo; Changqing Jiang
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

Review 6.  A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.

Authors:  Andrea Ghelli Luserna di Rorà; Claudio Cerchione; Giovanni Martinelli; Giorgia Simonetti
Journal:  J Hematol Oncol       Date:  2020-09-21       Impact factor: 17.388

7.  Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  Peng Chen; Ziying Zhang; Xiang Chen
Journal:  Med Sci Monit       Date:  2020-10-07

8.  PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis.

Authors:  Juan Chen; Xiaoliang Hua; Heying Chen; Xiangmin Qiu; Haibing Xiao; Shengdong Ge; Chaozhao Liang; Qin Zhou
Journal:  Aging (Albany NY)       Date:  2021-12-27       Impact factor: 5.682

9.  Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.

Authors:  Yiyang Hu; Chunli Gong; Zhibin Li; Jiao Liu; Yang Chen; Yu Huang; Qiang Luo; Sumin Wang; Yu Hou; Shiming Yang; Yufeng Xiao
Journal:  Mol Cancer       Date:  2022-02-03       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.